中文
中文

About Us

ABOUT US

Shenzhen Guanai International Pharmaceutical Co., Ltd. was founded in 1919 as the Central Epidemic Prevention Station. After the founding of the People's Republic of China it came directly under the Ministry of Health, and today it is a large integrated biopharmaceutical enterprise with several second-tier subsidiaries and R&D and manufacturing bases, more than ten thousand employees, and a leading position among China's long-established, full-product biopharmaceutical companies.

  • Company Profile

    The company integrates R&D, manufacturing, sales and postgraduate training, and keeps expanding across vaccines, blood products, biologics and diagnostic reagents, focusing on unmet clinical needs and safeguarding public health.

  • Milestones

    From the Central Epidemic Prevention Station to a modern biopharmaceutical enterprise, more than a century has brought a leap from workshop-style production to a full industry chain, from a single product line to multiple fields, and from domestic operations to international collaboration.

  • R&D Capability

    The company has established multiple national R&D platforms and key laboratories with full capabilities in drug discovery, clinical research and industrial transfer, and its pipeline spans prevention, treatment and diagnosis.

  • Quality System

    A risk-based quality management system built on GMP, EU GMP and ISO 9001, covering the entire product life cycle.

  • Talent Team

    A professional talent pipeline across R&D, manufacturing, quality and supply chain provides a solid foundation for continued innovation.

  • Global Cooperation

    The company maintains technical exchange with the World Health Organization and regulatory authorities worldwide, contributes to global vaccine supply security, and takes Chinese biopharmaceutical products to the world.